Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Instil Bio Inc has a consensus price target of $81.67 based on the ratings of 8 analysts. The high is $180 issued by Baird on September 16, 2024. The low is $2 issued by Morgan Stanley on December 12, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on September 11, 2025, August 27, 2025, and August 15, 2025, respectively. With an average price target of $125 between HC Wainwright & Co., there's an implied 839.78% upside for Instil Bio Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/11/2025 | 839.78% | HC Wainwright & Co. | $125 → $125 | Reiterates | Buy → Buy | |||
08/27/2025 | 839.78% | HC Wainwright & Co. | $125 → $125 | Reiterates | Buy → Buy | |||
08/15/2025 | 839.78% | HC Wainwright & Co. | $125 → $125 | Reiterates | Buy → Buy | |||
06/05/2025 | 839.78% | HC Wainwright & Co. | $125 → $125 | Reiterates | Buy → Buy | |||
06/02/2025 | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | |||
05/23/2025 | 839.78% | HC Wainwright & Co. | $105 → $125 | Maintains | Buy | |||
05/22/2025 | 689.41% | HC Wainwright & Co. | $110 → $105 | Maintains | Buy | |||
03/05/2025 | 727.01% | HC Wainwright & Co. | $110 → $110 | Reiterates | Buy → Buy | |||
02/13/2025 | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | |||
01/07/2025 | 290.95% | Jefferies | $11 → $52 | Upgrade | Hold → Buy | |||
11/18/2024 | 727.01% | HC Wainwright & Co. | $110 → $110 | Reiterates | Buy → Buy | |||
11/14/2024 | 727.01% | HC Wainwright & Co. | $120 → $110 | Maintains | Buy | |||
11/04/2024 | — | JMP Securities | — | Initiates | → Market Perform | |||
09/17/2024 | 802.19% | HC Wainwright & Co. | $120 → $120 | Reiterates | Buy → Buy | |||
09/16/2024 | 802.19% | HC Wainwright & Co. | $40 → $120 | Maintains | Buy | |||
09/16/2024 | 1253.28% | Baird | $180 → $180 | Reiterates | Outperform → Outperform | |||
09/13/2024 | 1253.28% | Baird | $32 → $180 | Maintains | Outperform | |||
09/12/2024 | 200.73% | HC Wainwright & Co. | $25 → $40 | Maintains | Buy | |||
08/23/2024 | 87.96% | HC Wainwright & Co. | $18 → $25 | Maintains | Buy | |||
08/05/2024 | 35.33% | HC Wainwright & Co. | $18 → $18 | Reiterates | Buy → Buy | |||
05/13/2024 | 35.33% | HC Wainwright & Co. | $18 → $18 | Reiterates | Buy → Buy | |||
05/13/2024 | 140.58% | Baird | $54 → $32 | Maintains | Outperform | |||
04/12/2024 | -17.3% | Jefferies | $5 → $11 | Downgrade | Buy → Hold | |||
03/25/2024 | 35.33% | HC Wainwright & Co. | $18 → $18 | Reiterates | Buy → Buy | |||
01/22/2024 | 35.33% | HC Wainwright & Co. | $2 → $18 | Maintains | Buy | |||
01/19/2024 | 305.98% | Baird | → $54 | Reiterates | Outperform → Outperform | |||
01/17/2024 | 305.98% | Baird | $100 → $54 | Maintains | Outperform | |||
11/14/2023 | -84.96% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy | |||
08/17/2023 | -84.96% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy | |||
06/29/2023 | -84.96% | HC Wainwright & Co. | → $2 | Initiates | → Buy | |||
04/05/2023 | -54.89% | Truist Securities | → $6 | Reinstates | → Hold | |||
12/12/2022 | -84.96% | Morgan Stanley | $6 → $2 | Maintains | Equal-Weight |
The latest price target for Instil Bio (NASDAQ:TIL) was reported by HC Wainwright & Co. on September 11, 2025. The analyst firm set a price target for $125.00 expecting TIL to rise to within 12 months (a possible 839.78% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
The last upgrade for Instil Bio Inc happened on January 7, 2025 when Jefferies raised their price target to $52. Jefferies previously had a hold for Instil Bio Inc.
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on September 11, 2025 so you should expect the next rating to be made available sometime around September 11, 2026.
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $125.00 to $125.00. The current price Instil Bio (TIL) is trading at is $13.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.